Human GDF-15 Antibody Summary
Accession # Q99988
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
GDF‑15 in HepG2 and U937 Human Cell Lines. GDF‑15 was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line (positive staining) and U937 human histiocytic lymphoma cell line (negative staining) using Mouse Anti-Human GDF‑15 Monoclonal Antibody (Catalog # MAB9573) at 8 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to nuclei. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Growth Differentiation Factor 15 (GDF-15), also called Macrophage inhibitory cytokine-1 (MIC-1), placental transforming growth factor-beta, prostate-derived factor, and placental bone morphogenetic protein, is a divergent member of the transforming growth factor beta (TGF-beta ) superfamily. GDF-15 is highly expressed in placenta and is expressed at lower levels in kidney, pancreas, prostate and colon. It is also widely expressed in brain. Similarly to other TGF-beta family proteins, GDF-15 is synthesized as a large precursor protein that is cleaved at the dibasic cleavage site (RXXR) to release the carboxy-terminal domain. The carboxy-terminal domain of GDF-15 contains the characteristic seven conserved cysteine residues necessary for the formation of the cysteine knot and the single interchain disulfide bond. Furthermore, the carboxy-terminal domain contains two additional cysteine residues that form a fourth intrachain disulfide bond. Biologically active GDF-15 is a disulfide-linked homodimer of the carboxy-terminal 112 amino acid residues. Mature human GDF-15 shares 66.1% and 68.7% amino acid sequence similarity with rat and mouse GDF-15, respectively, which are remarkably low homologies between species in TGF-beta superfamily. GDF-15 has been shown to have various functions, including inhibition of production of tumor necrosis factor alpha (TNF-alpha ) from lipopolysaccharide-stimulated macrophages, induction of cartilage formation, early-stage endochonadal bone formation, and promotion of neuronal survival.
- Bootcov, M.R. et al. (1997) Proc. Natl. Acad. Sci. USA 94:11514.
- Böttner, M. et al. (1999) Gene 237:105.
- Fairlie, W.D. et al. (1998) J. Leukoc. Biol 65:2.
- Fairlie, W.D. et al. (2001) J B.C 20:16911.
- Bauskin, A.R. et al. (2000) EMBO J. 19:2212.
- Strelau, J. et al. (2000) J. Neurosci. 20:8597.
- Schober, A. et al. (2001) J. Comp. Neurol. 439:32.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Cell and Tissue Staining Kits
Reviews for Human GDF-15 Antibody
There are currently no reviews for this product. Be the first to review Human GDF-15 Antibody and earn rewards!
Have you used Human GDF-15 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image